Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Shah Capital Management | 14.17M | $133.0M | 8.59% | -679.5K | 2026-06-30 |
| BlackRock, Inc. | 13.95M | $131.0M | 8.46% | +1.10M | 2026-06-30 |
| State Street Corp | 11.74M | $110.0M | 7.12% | +2.77M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.61M | $71.0M | 4.62% | +456.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 7.26M | $68.0M | 4.40% | +127.3K | 2026-06-30 |
| Sanofi | 6.88M | $64.0M | 4.17% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 6.03M | $56.0M | 3.66% | -2.06M | 2026-06-30 |
| Geode Capital Management, LLC | 4.21M | $39.0M | 2.55% | +309.0K | 2026-06-30 |
| Two Sigma Investments, LP | 4.09M | $38.0M | 2.48% | -- | 2026-06-30 |
| Coatue Management LLC | 3.84M | $36.0M | 2.33% | -- | 2026-06-30 |
